It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or
consider using other browsers such as Chrome, Firefox or Safari.
[S1] ACC® 20 mg/ml Oral Solution. Reg. No.: 48/10.3/0261. Composition: Each 1 ml of ACC 20 mg/ml ORAL SOLUTION contains 20 mg acetylcysteine. ATC Code: R05C B01.
[S1] ACC® 200 (effervescent tablets). Reg. No.: 29/10.2.2/0753. Composition: Each ACC 200 effervescent tablet contains: 200 mg acetylcysteine. Pharmacological Classification: A10.3 Medicines acting on the respiratory system – other.
[S1] ACC® 600 (effervescent tablets). Reg. No.: 45/10.3/0229. Composition: Each effervescent tablet contains 600 mg acetylcysteine. [S1] ACC® 600 ORAL POWDER. Reg. No.: 51/10.3/0816. Composition: Each sachet contains 600 mg of acetylcysteine. ATC Code: R05CB01.
For full prescribing information refer to the Sandoz Professional Information approved by the South African Health Products Regulatory Authority (SAHPRA).
Sandoz SA (Pty) Ltd, Reg. No. 1990/001979/07,
Magwa Crescent West,
Tel: +27 (11) 347 6600.
SANCAL Customer Call Centre: 0861 726 225.
Reporting of AEs: https://www.report.novartis.com